Literature DB >> 19527080

Cytokines - their pathogenic and therapeutic role in chronic viral hepatitis.

J R Larrubia1, S Benito-Martínez, J Miquel-Plaza, E Sanz-de-Villalobos, F González-Mateos, T Parra.   

Abstract

Cytokines make up a network of molecules involved in the regulation of immune response and organ functional homeostasis. Cytokines coordinate both physiological and pathological processes occurring in the liver during viral infection, including infection control, inflammation, regeneration, and fibrosis. Hepatitis B and hepatitis C viruses interfere with the complex cytokine network brought about by the immune system and liver cells in order to prevent an effective immune response, capable of viral control. This situation leads to intrahepatic sequestration of nonspecific inflammatory infiltrates that release proinflammatory cytokines, which in turn favor chronic inflammation and fibrosis. The therapeutical administration of cytokines such as interferon alpha may result in viral clearance during persistent infection, and revert this process.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19527080     DOI: 10.4321/s1130-01082009000500006

Source DB:  PubMed          Journal:  Rev Esp Enferm Dig        ISSN: 1130-0108            Impact factor:   2.086


  9 in total

Review 1.  Immune therapy for hepatitis B.

Authors:  Sheikh Mohammad Fazle Akbar; Mamun Al-Mahtab; Md Sakilur Islam Khan; Ruksana Raihan; Ananta Shrestha
Journal:  Ann Transl Med       Date:  2016-09

2.  Interferon-associated hepatic steatosis is related to discrepancies in biochemical and virological responses of chronic hepatitis C to IFN-based therapy.

Authors:  Chun-Hao Chen; Jee-Fu Huang; Chung-Feng Huang; Ming-Lun Yeh; Jeng-Fu Yang; Ming-Yen Hsieh; Nai-Jen Hou; Zu-Yau Lin; Shinn-Cherng Chen; Ming-Yuh Hsieh; Liang-Yen Wang; Wan-Long Chuang; Chia-Yen Dai; Ming-Lung Yu
Journal:  Hepatol Int       Date:  2012-07-07       Impact factor: 6.047

Review 3.  Hepatitis B virus infection in Latin America: a genomic medicine approach.

Authors:  Sonia Roman; Alexis Jose-Abrego; Nora Alma Fierro; Griselda Escobedo-Melendez; Claudia Ojeda-Granados; Erika Martinez-Lopez; Arturo Panduro
Journal:  World J Gastroenterol       Date:  2014-06-21       Impact factor: 5.742

Review 4.  Adaptive immune response during hepatitis C virus infection.

Authors:  Juan Ramón Larrubia; Elia Moreno-Cubero; Megha Uttam Lokhande; Silvia García-Garzón; Alicia Lázaro; Joaquín Miquel; Cristian Perna; Eduardo Sanz-de-Villalobos
Journal:  World J Gastroenterol       Date:  2014-04-07       Impact factor: 5.742

5.  Downregulation of the AU-rich RNA-binding protein ZFP36 in chronic HBV patients: implications for anti-inflammatory therapy.

Authors:  Wen-Jing Jin; Cai-Feng Chen; Hui-Yu Liao; Lu-Lu Gong; Xiao-Hui Yuan; Bin-Bin Zhao; Ding Zhang; Xia Feng; Jing-Jun Liu; Yu Wang; Guo-Feng Chen; Hui-Ping Yan; You-Wen He
Journal:  PLoS One       Date:  2012-03-09       Impact factor: 3.240

Review 6.  Is it possible to stop nucleos(t)ide analogue treatment in chronic hepatitis B patients?

Authors:  Elia Moreno-Cubero; Robert T Sánchez Del Arco; Julia Peña-Asensio; Eduardo Sanz de Villalobos; Joaquín Míquel; Juan Ramón Larrubia
Journal:  World J Gastroenterol       Date:  2018-05-07       Impact factor: 5.742

Review 7.  Drug Delivery Strategies for Antivirals against Hepatitis B Virus.

Authors:  Latavia Singh; Sunaina Indermun; Mershen Govender; Pradeep Kumar; Lisa C du Toit; Yahya E Choonara; Viness Pillay
Journal:  Viruses       Date:  2018-05-17       Impact factor: 5.048

Review 8.  Nature of Host Immunity during Hepatitis B Virus Infection and designing Immune Therapy.

Authors:  Sheikh Mf Akbar; Mamun Al-Mahtab; Sakirul I Khan
Journal:  Euroasian J Hepatogastroenterol       Date:  2018-05-01

9.  Intrahepatic interleukin 10 expression modulates fibrinogenesis during chronic HCV infection.

Authors:  Ednelza da Silva Graça Amoras; Samara Tatielle Monteiro Gomes; Maria Alice Freitas Queiroz; Mauro Sergio Moura de Araújo; Marialva Tereza Ferreira de Araújo; Simone Regina Souza da Silva Conde; Ricardo Ishak; Antonio Carlos Rosário Vallinoto
Journal:  PLoS One       Date:  2020-10-30       Impact factor: 3.240

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.